NRG-CC005

Open to Accrual

Return to Protocol Table

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Principal Investigator

Robert Schoen, MD

Co-Principal Investigator(s)

Jeffrey Dueker, MD

Status

Open to Accrual

Date Opened To Accrual

October 06 2021

Disease Site

Prevention [CC]

Colorectal

Phase

III

Developmental Therapeutics

Primary Objective

To examine colorectal cancer incidence in participantswith 1 to 2 non-advanced adenomas randomized to surveillance colonoscopy at 10years compared to participants randomized to surveillance colonoscopy at 5 and 10 years.

Patient Population

Participants ≥ 50 and < 70 years with First Diagnosis of 1-2 Non-Advanced Adenomas within Prior 4 years.

Target Accrual

9500

Protocol Documents

Available via the National Cancer Institute (NCI) Cancer Trials Support Unit (CTSU) website.

Other

NRG-CC005 Request for Supplies from NRG Biobank PGH

Patient Study Webpage

To learn more about this study, visit the Patient Study Webpage.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.